gibreel ferishta
The risk of India’s generic drugs being labelled counterfeit under the new definition proposed by WHO has receded, a government represe
ntative concerned with the issue said. This would ensure that India’s manufacturers continue to sell their drugs in foreign markets.
The WHO-funded International Medical Products Anti-Counterfeiting Taskforce (IMPACT) had proposed a new definition of counterfeit drugs as medical products with a “false representation about their identity, history or source”.
drugs generics WHO IMPACT counterfeit pharmaceuticals IP
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.